Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients?

{ 'indexed': {'date-parts': [[2022, 8, 6]], 'date-time': '2022-08-06T15:07:18Z', 'timestamp': 1659798438689}, 'reference-count': 48, 'publisher': 'Springer Science and Business Media LLC', 'issue': '3', 'license': [ { 'start': { 'date-parts': [[2021, 4, 22]], 'date-time': '2021-04-22T00:00:00Z', 'timestamp': 1619049600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}, { 'start': { 'date-parts': [[2021, 4, 22]], 'date-time': '2021-04-22T00:00:00Z', 'timestamp': 1619049600000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2021, 6]]}, 'DOI': '10.1007/s40495-021-00257-6', 'type': 'journal-article', 'created': {'date-parts': [[2021, 4, 22]], 'date-time': '2021-04-22T22:02:52Z', 'timestamp': 1619128972000}, 'page': '102-106', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 3, 'title': 'Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients?', 'prefix': '10.1007', 'volume': '7', 'author': [ {'given': 'Myasar', 'family': 'Alkotaji', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-2067-4531', 'authenticated-orcid': False, 'given': 'Radhwan N.', 'family': 'Al-Zidan', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2021, 4, 22]]}, 'reference': [ { 'issue': '5', 'key': '257_CR1', 'doi-asserted-by': 'publisher', 'first-page': '533', 'DOI': '10.1016/S1473-3099(20)30120-1', 'volume': '20', 'author': 'E Dong', 'year': '2020', 'unstructured': 'Dong E, Du H, Gardner L. An interactive web-based dashboard to track ' 'COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4.', 'journal-title': 'Lancet Infect Dis'}, { 'issue': '13', 'key': '257_CR2', 'doi-asserted-by': 'publisher', 'first-page': '1239', 'DOI': '10.1001/jama.2020.2648', 'volume': '323', 'author': 'Z Wu', 'year': '2020', 'unstructured': 'Wu Z, McGoogan JM. Characteristics of and important lessons from the ' 'coronavirus disease 2019 (COVID-19) outbreak in China: summary of a ' 'report of 72\xa0314 cases from the Chinese Center for Disease Control ' 'and Prevention. JAMA. 2020;323(13):1239–42.', 'journal-title': 'JAMA.'}, { 'key': '257_CR3', 'unstructured': 'Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, ' 'evaluation and treatment coronavirus (COVID-19). Statpearls. 2020.'}, { 'issue': '11', 'key': '257_CR4', 'doi-asserted-by': 'publisher', 'first-page': '1448', 'DOI': '10.1016/j.cmi.2020.07.028', 'volume': '26', 'author': 'B Davido', 'year': '2020', 'unstructured': 'Davido B, Seang S, Tubiana R, de Truchis P. Post–COVID-19 chronic ' 'symptoms: a postinfectious entity? Clin Microbiol Infect. ' '2020;26(11):1448–9.', 'journal-title': 'Clin Microbiol Infect'}, { 'issue': '6', 'key': '257_CR5', 'doi-asserted-by': 'publisher', 'first-page': '603', 'DOI': '10.1001/jama.2020.12603', 'volume': '324', 'author': 'A Carfì', 'year': '2020', 'unstructured': 'Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after ' 'acute COVID-19. JAMA. 2020;324(6):603–5.', 'journal-title': 'JAMA.'}, { 'issue': '6', 'key': '257_CR6', 'doi-asserted-by': 'publisher', 'first-page': 'e790', 'DOI': '10.1016/S2214-109X(20)30204-7', 'volume': '8', 'author': 'Q Liu', 'year': '2020', 'unstructured': 'Liu Q, Luo D, Haase JE, Guo Q, Wang XQ, Liu S, et al. The experiences of ' 'health-care providers during the COVID-19 crisis in China: a qualitative ' 'study. Lancet Glob Health. 2020;8(6):e790–e8.', 'journal-title': 'Lancet Glob Health'}, { 'key': '257_CR7', 'doi-asserted-by': 'crossref', 'unstructured': 'Liu Y, Wang M, Luo G, Qian X, Wu C, Zhang Y, et al. Experience of ' 'N-acetylcysteine airway management in the successful treatment of one ' 'case of critical condition with COVID-19: a case report. Medicine. ' '2020;99(42).', 'DOI': '10.1097/MD.0000000000022577'}, { 'key': '257_CR8', 'unstructured': 'Barzegar AGM, Rezaei N, Forouzesh M. Valizadeh R. New hope for treatment ' 'of respiratory involvement following COVID-19 by bromhexine. J ' 'Nephropharmacol. 2021;10(2).'}, { 'issue': '6', 'key': '257_CR9', 'doi-asserted-by': 'publisher', 'first-page': '106192', 'DOI': '10.1016/j.ijantimicag.2020.106192', 'volume': '56', 'author': 'M Alkotaji', 'year': '2020', 'unstructured': 'Alkotaji M. Azithromycin and ambroxol as potential pharmacotherapy for ' 'SARS-CoV-2. Int J Antimicrob Agents. 2020;56(6):106192.', 'journal-title': 'Int J Antimicrob Agents'}, { 'issue': '10', 'key': '257_CR10', 'doi-asserted-by': 'publisher', 'first-page': '682', 'DOI': '10.1055/a-1152-3469', 'volume': '145', 'author': 'R Kreutz', 'year': '2020', 'unstructured': 'Kreutz R, Algharably EAE-H, Ganten D, Messerli F. ' 'Renin-angiotensin-system (RAS) und COVID-19–Zur Verordnung von ' 'RAS-Blockern. Dtsch Med Wochenschr (1946). 2020;145(10):682.', 'journal-title': 'Dtsch Med Wochenschr'}, { 'key': '257_CR11', 'doi-asserted-by': 'publisher', 'first-page': '285', 'DOI': '10.1016/j.jaci.2020.05.033', 'volume': '146', 'author': 'K Hosoki', 'year': '2020', 'unstructured': 'Hosoki K, Chakraborty A, Sur S. Molecular mechanisms and epidemiology of ' 'COVID-19 from an allergist’s perspective. J Allergy Clin Immunol. ' '2020;146:285–99.', 'journal-title': 'J Allergy Clin Immunol'}, { 'key': '257_CR12', 'doi-asserted-by': 'crossref', 'unstructured': 'van de Veerdonk F, Netea MG, Van Deuren M, Van Der Meer JW, De Mast Q, ' 'Bruggemann RJ, et al. Kinins and cytokines in COVID-19: a comprehensive ' 'pathophysiological approach. 2020.', 'DOI': '10.20944/preprints202004.0023.v1'}, { 'issue': '6', 'key': '257_CR13', 'doi-asserted-by': 'publisher', 'first-page': '1454', 'DOI': '10.1016/j.jaci.2020.08.038', 'volume': '146', 'author': 'S Zwaveling', 'year': '2020', 'unstructured': 'Zwaveling S, van Wijk RG, Karim F. Pulmonary edema in COVID-19: ' 'explained by bradykinin? J Allergy Clin Immunol. 2020;146(6):1454–5.', 'journal-title': 'J Allergy Clin Immunol'}, { 'issue': '2', 'key': '257_CR14', 'doi-asserted-by': 'publisher', 'first-page': 'e19-e', 'DOI': '10.34172/jrip.2020.19', 'volume': '9', 'author': 'R Tolouian', 'year': '2020', 'unstructured': 'Tolouian R, Vahed SZ, Ghiyasvand S, Tolouian A, Ardalan M. COVID-19 ' 'interactions with angiotensin-converting enzyme 2 (ACE2) and the kinin ' 'system; looking at a potential treatment. J Ren Inj Prev. ' '2020;9(2):e19-e.', 'journal-title': 'J Ren Inj Prev'}, { 'issue': '1', 'key': '257_CR15', 'doi-asserted-by': 'publisher', 'first-page': '36', 'DOI': '10.5152/TurkThoracJ.2018.18014', 'volume': '20', 'author': 'İ Yılmaz', 'year': '2019', 'unstructured': 'Yılmaz İ. Angiotensin-converting enzyme inhibitors induce cough. Turk ' 'Thorac J. 2019;20(1):36–42.', 'journal-title': 'Turk Thorac J'}, { 'issue': '6', 'key': '257_CR16', 'doi-asserted-by': 'publisher', 'first-page': '7265', 'DOI': '10.1096/fj.202000967', 'volume': '34', 'author': 'JA Roche', 'year': '2020', 'unstructured': 'Roche JA, Roche R. A hypothesized role for dysregulated bradykinin ' 'signaling in COVID-19 respiratory complications. FASEB J. ' '2020;34(6):7265–9.', 'journal-title': 'FASEB J'}, { 'key': '257_CR17', 'doi-asserted-by': 'crossref', 'unstructured': 'Ghahestani S-M, Mahmoudi J, Hajebrahimi S, Khojine ABS, Salehi-Pourmehr ' 'H, Sadeghi-Ghyassi F, et al. Bradykinin as a probable aspect in ' 'SARS-Cov-2 scenarios: is bradykinin sneaking out of our sight? Iran J ' 'Allergy Asthma Immunol. 2020:1–5.', 'DOI': '10.18502/ijaai.v19i(s1.r1).2850'}, { 'key': '257_CR18', 'doi-asserted-by': 'publisher', 'first-page': 'e57555', 'DOI': '10.7554/eLife.57555', 'volume': '9', 'author': 'FL van de Veerdonk', 'year': '2020', 'unstructured': 'van de Veerdonk FL, Netea MG, van Deuren M, van der Meer JW, de Mast Q, ' 'Brüggemann RJ, et al. Kallikrein-kinin blockade in patients with ' 'COVID-19 to prevent acute respiratory distress syndrome. Elife. ' '2020;9:e57555.', 'journal-title': 'Elife.'}, { 'issue': '8', 'key': '257_CR19', 'doi-asserted-by': 'publisher', 'first-page': 'e2017708-e', 'DOI': '10.1001/jamanetworkopen.2020.17708', 'volume': '3', 'author': 'FL van de Veerdonk', 'year': '2020', 'unstructured': 'van de Veerdonk FL, Kouijzer IJ, de Nooijer AH, van der Hoeven HG, Maas ' 'C, Netea MG, et al. Outcomes associated with use of a kinin B2 receptor ' 'antagonist among patients with COVID-19. JAMA Netw Open. ' '2020;3(8):e2017708-e.', 'journal-title': 'JAMA Netw Open'}, { 'key': '257_CR20', 'doi-asserted-by': 'publisher', 'DOI': '10.7554/eLife.59177', 'volume': '9', 'author': 'MR Garvin', 'year': '2020', 'unstructured': 'Garvin MR, Alvarez C, Miller JI, Prates ET, Walker AM, Amos BK, et al. A ' 'mechanistic model and therapeutic interventions for COVID-19 involving a ' 'RAS-mediated bradykinin storm. Elife. 2020;9:e59177.', 'journal-title': 'Elife.'}, { 'issue': '4', 'key': '257_CR21', 'doi-asserted-by': 'publisher', 'first-page': '1020', 'DOI': '10.1038/ki.1992.383', 'volume': '42', 'author': 'I Gavras', 'year': '1992', 'unstructured': 'Gavras I. Bradykinin-mediated effects of ACE inhibition. Kidney Int. ' '1992;42(4):1020–9.', 'journal-title': 'Kidney Int'}, { 'issue': '2', 'key': '257_CR22', 'doi-asserted-by': 'publisher', 'first-page': '361', 'DOI': '10.1161/HYPERTENSIONAHA.118.11070', 'volume': '72', 'author': 'D-D Zhang', 'year': '2018', 'unstructured': 'Zhang D-D, Gao Z-X, Vio CP, Xiao Y, Wu P, Zhang H, et al. Bradykinin ' 'stimulates renal Na+ and K+ excretion by inhibiting the K+ channel ' '(Kir4.1) in the distal convoluted tubule. Hypertension. ' '2018;72(2):361–9.', 'journal-title': 'Hypertension.'}, { 'key': '257_CR23', 'doi-asserted-by': 'publisher', 'first-page': '1500', 'DOI': '10.3389/fphys.2018.01500', 'volume': '9', 'author': 'J Skogestad', 'year': '2018', 'unstructured': 'Skogestad J, Aronsen JM. Hypokalemia-induced arrhythmias and heart ' 'failure: new insights and implications for therapy. Front Physiol. ' '2018;9:1500.', 'journal-title': 'Front Physiol'}, { 'issue': '3', 'key': '257_CR24', 'doi-asserted-by': 'publisher', 'first-page': '262', 'DOI': '10.1177/0004563220922255', 'volume': '57', 'author': 'G Lippi', 'year': '2020', 'unstructured': 'Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with ' 'severe coronavirus disease 2019 (COVID-19). Ann Clin Biochem. ' '2020;57(3):262–5.', 'journal-title': 'Ann Clin Biochem'}, { 'issue': '11', 'key': '257_CR25', 'doi-asserted-by': 'publisher', 'first-page': '1061', 'DOI': '10.1001/jama.2020.1585', 'volume': '323', 'author': 'D Wang', 'year': '2020', 'unstructured': 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical ' 'characteristics of 138 hospitalized patients with 2019 novel ' 'coronavirus–infected pneumonia in Wuhan, China. JAMA. ' '2020;323(11):1061–9.', 'journal-title': 'JAMA.'}, { 'issue': '10223', 'key': '257_CR26', 'doi-asserted-by': 'publisher', 'first-page': '497', 'DOI': '10.1016/S0140-6736(20)30183-5', 'volume': '395', 'author': 'C Huang', 'year': '2020', 'unstructured': 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of ' 'patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. ' '2020;395(10223):497–506.', 'journal-title': 'Lancet.'}, { 'issue': '7', 'key': '257_CR27', 'doi-asserted-by': 'publisher', 'first-page': '811', 'DOI': '10.1001/jamacardio.2020.1017', 'volume': '5', 'author': 'T Guo', 'year': '2020', 'unstructured': 'Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular ' 'implications of fatal outcomes of patients with coronavirus disease 2019 ' '(COVID-19). JAMA Cardiol. 2020;5(7):811–8.', 'journal-title': 'JAMA Cardiol'}, { 'key': '257_CR28', 'doi-asserted-by': 'publisher', 'first-page': 'm1086', 'DOI': '10.1136/bmj.m1086', 'volume': '368', 'author': 'M Day', 'year': '2020', 'unstructured': 'Day M. Covid-19: ibuprofen should not be used for managing symptoms, say ' 'doctors and scientists. BMJ. 2020;368:m1086.', 'journal-title': 'BMJ.'}, { 'key': '257_CR29', 'unstructured': 'Moore N, Carleton B, Blin P, Bosco-Levy P, Droz C. Does ibuprofen worsen ' 'COVID-19?'}, { 'key': '257_CR30', 'unstructured': 'Updated AF. WHO now doesn’t recommend avoiding ibuprofen for COVID-19 ' 'symptoms. ScienceAlert. Retrieved. 2020;19.'}, { 'key': '257_CR31', 'first-page': '1', 'volume': '2', 'author': 'LC Esba', 'year': '2020', 'unstructured': 'Esba LC, Alqahtani RA, Thomas A, Shamas N, Alswaidan L, Mardawi G. ' 'Ibuprofen and NSAID use in COVID-19 infected patients is not associated ' 'with worse outcomes: a prospective cohort study. Infect Dis Ther. ' '2020;2:1–6.', 'journal-title': 'Infect Dis Ther'}, { 'issue': '7', 'key': '257_CR32', 'doi-asserted-by': 'publisher', 'first-page': '814', 'DOI': '10.1038/nm0796-814', 'volume': '2', 'author': 'AJ Fox', 'year': '1996', 'unstructured': 'Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ. ' 'Bradykinin–evoked sensitization of airway sensory nerves: a mechanism ' 'for ACE–inhibitor cough. Nat Med. 1996;2(7):814–7.', 'journal-title': 'Nat Med'}, { 'issue': '1', 'key': '257_CR33', 'doi-asserted-by': 'publisher', 'first-page': '1', 'DOI': '10.1186/s12931-019-1060-8', 'volume': '20', 'author': 'F Al-Shamlan', 'year': '2019', 'unstructured': 'Al-Shamlan F, El-Hashim AZ. Bradykinin sensitizes the cough reflex via a ' 'B 2 receptor dependent activation of TRPV1 and TRPA1 channels through ' 'metabolites of cyclooxygenase and 12-lipoxygenase. Respir Res. ' '2019;20(1):1–15.', 'journal-title': 'Respir Res'}, { 'issue': '4', 'key': '257_CR34', 'doi-asserted-by': 'publisher', 'first-page': '212', 'DOI': '10.1159/000196201', 'volume': '60', 'author': 'M Cazzola', 'year': '1993', 'unstructured': 'Cazzola M, Matera MG, Liccardi G, De Prisco F, D’Amato G, Rossi F. ' 'Theophylline in the inhibition of angiotensin-converting enzyme ' 'inhibitor-induced cough. Respiration. 1993;60(4):212–5.', 'journal-title': 'Respiration.'}, { 'issue': '8941', 'key': '257_CR35', 'doi-asserted-by': 'publisher', 'first-page': '13', 'DOI': '10.1016/S0140-6736(95)91151-0', 'volume': '345', 'author': 'M Hargreaves', 'year': '1995', 'unstructured': 'Hargreaves M, Benson M. Inhaled sodium cromoglycate in ' 'angiotensin-converting enzyme inhibitor cough. Lancet. ' '1995;345(8941):13–6.', 'journal-title': 'Lancet'}, { 'issue': '3', 'key': '257_CR36', 'doi-asserted-by': 'publisher', 'first-page': '121', 'DOI': '10.1016/S0011-393X(00)88520-3', 'volume': '60', 'author': 'R Fogari', 'year': '1999', 'unstructured': 'Fogari R, Zoppi A, Mugellini A, Preti P, Banderali A, Salvetti A. ' 'Effects of amlodipine, nifedipine GITS, and indomethacin on ' 'angiotensin-converting enzyme inhibitor-induced cough: a randomized, ' 'placebo-controlled, double-masked, crossover study. Curr Ther Res. ' '1999;60(3):121–8.', 'journal-title': 'Curr Ther Res'}, { 'issue': '1', 'key': '257_CR37', 'first-page': '161', 'volume': '255', 'author': 'JR McEWAN', 'year': '1990', 'unstructured': 'McEWAN JR, Choudry NB, Fuller RW. The effect of sulindac on the abnormal ' 'cough reflex associated with dry cough. J Pharmacol Exp Ther. ' '1990;255(1):161–4.', 'journal-title': 'J Pharmacol Exp Ther'}, { 'issue': '7', 'key': '257_CR38', 'doi-asserted-by': 'publisher', 'first-page': '776', 'DOI': '10.1016/S0895-7061(00)00268-5', 'volume': '13', 'author': 'A Tenenbaum', 'year': '2000', 'unstructured': 'Tenenbaum A, Grossman E, Shemesh J, Fisman EZ, Nosrati I, Motro M. ' 'Intermediate but not low doses of aspirin can suppress ' 'angiotensin-converting enzyme inhibitor-induced cough. Am J Hypertens. ' '2000;13(7):776–82.', 'journal-title': 'Am J Hypertens'}, { 'issue': '2', 'key': '257_CR39', 'doi-asserted-by': 'publisher', 'first-page': '166', 'DOI': '10.1161/01.HYP.38.2.166', 'volume': '38', 'author': 'S-C Lee', 'year': '2001', 'unstructured': 'Lee S-C, Park SW, Kim D-K, Lee SH, Hong KP. Iron supplementation ' 'inhibits cough associated with ACE inhibitors. Hypertension. ' '2001;38(2):166–70.', 'journal-title': 'Hypertension.'}, { 'issue': '1', 'key': '257_CR40', 'doi-asserted-by': 'publisher', 'first-page': '169S', 'DOI': '10.1378/chest.129.1_suppl.169S', 'volume': '129', 'author': 'PV Dicpinigaitis', 'year': '2006', 'unstructured': 'Dicpinigaitis PV. Angiotensin-converting enzyme inhibitor-induced cough: ' 'ACCP evidence-based clinical practice guidelines. Chest. ' '2006;129(1):169S–73S.', 'journal-title': 'Chest.'}, { 'key': '257_CR41', 'doi-asserted-by': 'crossref', 'unstructured': 'Little P. Non-steroidal anti-inflammatory drugs and covid-19: British ' 'Medical Journal Publishing Group; 2020.', 'DOI': '10.1136/bmj.m1185'}, { 'issue': '5', 'key': '257_CR42', 'doi-asserted-by': 'publisher', 'first-page': '401', 'DOI': '10.3109/00365519709084587', 'volume': '57', 'author': 'A Mäkelä', 'year': '1997', 'unstructured': 'Mäkelä A, Kuusi T, Schröder T. Inhibition of serum phospholipase-A2 in ' 'acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab ' 'Invest. 1997;57(5):401–7.', 'journal-title': 'Scand J Clin Lab Invest'}, { 'issue': '4', 'key': '257_CR43', 'doi-asserted-by': 'publisher', 'first-page': '856', 'DOI': '10.1111/j.1572-0241.2005.41144.x', 'volume': '100', 'author': 'H Bahrami', 'year': '2005', 'unstructured': 'Bahrami H, Daryani NE, Haghpanah B, Moayyeri A, Moghadam KF, Mirmomen S, ' 'et al. Effects of indomethacin on viral replication markers in ' 'asymptomatic carriers of hepatitis B: a randomized, placebo-controlled ' 'trial. Am J Gastroenterol. 2005;100(4):856–61.', 'journal-title': 'Am J Gastroenterol'}, { 'issue': '9', 'key': '257_CR44', 'doi-asserted-by': 'publisher', 'first-page': '957', 'DOI': '10.1080/003655200750023020', 'volume': '35', 'author': 'S Kapiciogğlu', 'year': '2000', 'unstructured': 'Kapiciogğlu S, Sari M, Kaynar K, Baki A, Özoran Y. The effect of ' 'indomethacin on hepatitis B virus replication in chronic healthy ' 'carriers. Scand J Gastroenterol. 2000;35(9):957–9.', 'journal-title': 'Scand J Gastroenterol'}, { 'issue': '9', 'key': '257_CR45', 'doi-asserted-by': 'publisher', 'first-page': '1391', 'DOI': '10.1111/cmi.12446', 'volume': '17', 'author': 'C Amici', 'year': '2015', 'unstructured': 'Amici C, La Frazia S, Brunelli C, Balsamo M, Angelini M, Santoro MG. ' 'Inhibition of viral protein translation by indomethacin in vesicular ' 'stomatitis virus infection: role of eif2α kinase PKR. Cell Microbiol. ' '2015;17(9):1391–404.', 'journal-title': 'Cell Microbiol'}, { 'issue': '2', 'key': '257_CR46', 'doi-asserted-by': 'publisher', 'first-page': '436', 'DOI': '10.1111/head.12769', 'volume': '56', 'author': 'S Lucas', 'year': '2016', 'unstructured': 'Lucas S. The pharmacology of indomethacin. Headache Head Face Pain. ' '2016;56(2):436–46.', 'journal-title': 'Headache Head Face Pain'}, { 'issue': '6', 'key': '257_CR47', 'doi-asserted-by': 'publisher', 'first-page': '219', 'DOI': '10.22270/jddt.v10i6.4383', 'volume': '10', 'author': 'RN Al-Zidan', 'year': '2020', 'unstructured': 'Al-Zidan RN. Potential drug-drug and drug-disease interactions of ' 'selected experimental therapies used in treating COVID-19 patients. J ' 'Drug Deliv Ther. 2020;10(6):219–30.', 'journal-title': 'J Drug Deliv Ther'}, { 'issue': '7', 'key': '257_CR48', 'doi-asserted-by': 'publisher', 'first-page': '2291', 'DOI': '10.3390/ph3072291', 'volume': '3', 'author': 'WH Hörl', 'year': '2010', 'unstructured': 'Hörl WH. Nonsteroidal anti-inflammatory drugs and the kidney. ' 'Pharmaceuticals. 2010;3(7):2291–321.7.', 'journal-title': 'Pharmaceuticals.'}], 'container-title': 'Current Pharmacology Reports', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s40495-021-00257-6.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s40495-021-00257-6/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s40495-021-00257-6.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 5, 25]], 'date-time': '2021-05-25T05:38:08Z', 'timestamp': 1621921088000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s40495-021-00257-6'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 4, 22]]}, 'references-count': 48, 'journal-issue': {'issue': '3', 'published-print': {'date-parts': [[2021, 6]]}}, 'alternative-id': ['257'], 'URL': 'http://dx.doi.org/10.1007/s40495-021-00257-6', 'relation': {}, 'ISSN': ['2198-641X'], 'subject': ['Drug Discovery', 'Pharmacology', 'Genetics', 'Biochemistry'], 'container-title-short': 'Curr Pharmacol Rep', 'published': {'date-parts': [[2021, 4, 22]]}, 'assertion': [ { 'value': '16 April 2021', 'order': 1, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '22 April 2021', 'order': 2, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'Not applicable.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Ethics Approval and Consent to Participate'}}, { 'value': 'Not applicable.', 'order': 3, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Consent for Publication'}}, { 'value': 'The authors declare that there is no conflict of interest.', 'order': 4, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Conflict of Interest'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}